Jushi Holdings (JUSHF) Change in Accured Expenses (2021 - 2026)

Jushi Holdings' (JUSHF) quarterly Change in Accured Expenses came in at $3.7 million in Q1 2026, down 36.27% year-on-year from $5.7 million in Q1 2025, and up 325.42% on a QoQ basis from -$1.6 million in Q4 2025.

Jushi Holdings (JUSHF) Change in Accured Expenses (2021 - 2026) Analysis & Trends

Jushi Holdings (JUSHF) has 6 years of Change in Accured Expenses data on file, last reported at $3.7 million in Q1 2026.

  • On a quarterly basis, Change in Accured Expenses fell 36.27% year-over-year to $3.7 million in Q1 2026; TTM through Mar 2026 was -$1.2 million, a 112.56% decrease from a year earlier, with the FY2025 full-year figure at $893000.0, down 90.93% from the prior year.
  • Change in Accured Expenses for Q1 2026 stood at $3.7 million, up from -$1.6 million in the prior quarter.
  • Over the last five years, Change in Accured Expenses for JUSHF reached as high as $10.8 million in Q4 2022 and fell as low as -$10.6 million in Q3 2023.
  • Historically, Change in Accured Expenses has averaged $2.0 million across 5 years, with a median of $3.7 million in 2026.
  • Across the five-year window, Change in Accured Expenses soared 437.66% in 2023 and slumped 1238.68% in 2025, its largest moves.
  • Year by year, Change in Accured Expenses stood at $10.8 million in 2022, then tumbled by 117.74% to -$1.9 million in 2023, then soared by 128.88% to $553000.0 in 2024, then slumped by 393.85% to -$1.6 million in 2025, then surged by 325.42% to $3.7 million in 2026.
  • Per Business Quant data, the three most recent Change in Accured Expenses figures were $3.7 million in Q1 2026, -$1.6 million in Q4 2025, and $5.3 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn -144.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -234.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -12.70 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -14.30 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -
10 Jushi Holdings 81.25 Mn 41.54 Mn 29.88 Mn 3.66 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 3.66 Mn
Mar 31, 2026 3.66 Mn
Dec 31, 2025 -1.63 Mn
Dec 31, 2025 -1.63 Mn
Sep 30, 2025 5.28 Mn
Sep 30, 2025 5.28 Mn
Jun 30, 2025 -8.51 Mn
Jun 30, 2025 -8.51 Mn
Mar 31, 2025 5.75 Mn
Mar 31, 2025 5.75 Mn
Dec 31, 2024 553,000.00
Dec 31, 2024 553,000.00
Sep 30, 2024 3.83 Mn
Sep 30, 2024 3.83 Mn
Jun 30, 2024 -636,000.00
Jun 30, 2024 -636,000.00
Mar 31, 2024 6.10 Mn
Mar 31, 2024 6.10 Mn
Dec 31, 2023 -1.92 Mn
Dec 31, 2023 -1.92 Mn